Bioanalysis of N-acetyl-aspartyl-glutamate as a marker of glutamate carboxypeptidase II inhibition

Analytical Biochemistry

Volumn 404, Issue 1, 2010, Pages 94-96

  Thomas, Ajit G ^a   Rojas, Camilo J ^a   Hill, Jeanette R ^b   Shaw, Michael ^b   Slusher, Barbara S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CellzDirect Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROSPINAL FLUID; MASS SPECTROMETRY;

BIOLOGICAL FLUIDS; BIOLOGICAL MATRIXES; CARBOXYPEPTIDASE; EXPERIMENTAL ERRORS; FLUORESCENCE DETECTION; HUMAN CEREBROSPINAL FLUID; INDEPENDENT MEASUREMENT; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC MS/MS);

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

GLUTAMATE CARBOXYPEPTIDASE II; N ACETYLASPARTYLGLUTAMIC ACID; BIOLOGICAL MARKER; DIPEPTIDE; N-ACETYL-1-ASPARTYLGLUTAMIC ACID;

ANALYTIC METHOD; ARTICLE; CEREBROSPINAL FLUID; ENZYME ANALYSIS; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; LIQUID CHROMATOGRAPHY; METHODOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STOICHIOMETRY; TANDEM MASS SPECTROMETRY; ANTAGONISTS AND INHIBITORS; METABOLISM; PROCEDURES;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIPEPTIDES; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; HYDROLYSIS; TANDEM MASS SPECTROMETRY;

EID: 77954089155     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.04.029     Document Type: Article

References (16)

1. Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol. Ther. 1999, 81:163-221.
2. Neale J.H., Olszewski R.T., Gehl L.M., Wroblewska B., Bzdega T. The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury, and schizophrenia. Trends Pharmacol. Sci. 2005, 26:477-484.
3. Berger U.V., Carter R.E., McKee M., Coyle J.T. N-Acetylated α-linked acidic dipeptidase is expressed by non-myelinating Schwann cells in the peripheral nervous system. J. Neurocytol. 1995, 24:99-109.
4. Cassidy M., Neale J.H. N-Acetylaspartylglutamate catabolism is achieved by an enzyme on the cell surface of neurons and glia. Neuropeptides 1993, 24:271-278.
5. Robinson M.B., Coyle J.T. Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application. FASEB J. 1987, 1:446-455.
6. Zhou J., Neale J.H., Pomper M.G., Kozikowski A.P. NAAG peptidase inhibitors and their potential for diagnosis and therapy. Nat. Rev. Drug Discov. 2005, 4:1015-1026.
7. van der Post J.P., de Visser S.J., de Kam M.L., Woelfler M., Hilt D.C., Vornov J., Burak E.S., Bortey E., Slusher B.S., Limsakun T., Cohen A.F., van Gerven J.M. The central nervous system effects, pharmacokinetics, and safety of the NAALADase-inhibitor GPI 5693. Br. J. Clin. Pharmacol. 2005, 60:128-136.
8. Slusher B.S., Robinson M.B., Tsai G., Simmons M.L., Richards S.S., Coyle J.T. Rat brain N-acetylated α-linked acidic dipeptidase activity: purification and immunologic characterization. J. Biol. Chem. 1990, 265:21297-21301.
9. Brovia V., Ricciardi A., Barbeito L. N-Acetyl-aspartylglutamate (NAAG) in human cerebrospinal fluid: determination by high performance liquid chromatography and influence of biological variables. Amino Acids 1995, 9:175-184.
10. Koller K.J., Zaczek R., Coyle J.T. N-Acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J. Neurochem. 1984, 43:1136-1142.
11. Rothstein J.D., Tsai G., Kuncl R.W., Clawson L., Cornblath D.R., Drachman D.B., Pestronk A., Stauch B.L., Coyle J.T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 1990, 28:18-25.
12. Faull K.F., Rafie R., Pascoe N., Marsh L., Pfefferbaum A. N-Acetylaspartic acid (NAA) and N-acetylaspartylglutamic acid (NAAG) in human ventricular, subarachnoid, and lumbar cerebrospinal fluid. Neurochem. Res. 1999, 24:1249-1261.
13. Wolf N.I., Willemsen M.A., Engelke U.F., van der Knaap M.S., Pouwels P.J., Harting I., Zschocke J., Sistermans E.A., Rating D., Wevers R.A. Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF. Neurology 2004, 62:1503-1508.
14. Burlina A.P., Ferrari V., Divry P., Gradowska W., Jakobs C., Bennett M.J., Sewell A.C., Dionisi-Vici C., Burlina A.B. N-Acetylaspartylglutamate in Canavan disease: an adverse effector?. Eur. J. Pediatr. 1999, 158:406-409.
15. Hashimoto A., Nishikawa T., Oka T., Takahashi K., Hayashi T. Determination of free amino acid enantiomers in rat brain and serum by high-performance liquid chromatography after derivatization with N-tert-butyloxycarbonyl-l-cysteine and o-phthaldialdehyde. J. Chromatogr. 1992, 582:41-48.
16. Morikawa A., Hamase K., Inoue T., Konno R., Niwa A., Zaitsu K. Determination of free d-aspartic acid, d-serine, and d-alanine in the brain of mutant mice lacking d-amino acid oxidase activity. J. Chromatogr. B 2001, 757:119-125.